TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells

Apoptosis

Volumn 17, Issue 8, 2012, Pages 749-761

  Huang, Yusheng ^a   Dai, Huanzi ^a   Guo, Qiao Nan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Osteosarcoma; TSSC3; Tumor initiating cell

Indexed keywords

BETA ACTIN; CASPASE 3; CYTOCHROME C; OCTAMER TRANSCRIPTION FACTOR 4; PROCASPASE 3; PROCASPASE 9; PROTEIN TSSC3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER RELAPSE; CARCINOGENICITY; CELL DIFFERENTIATION; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME RELEASE; FEMALE; GENE OVEREXPRESSION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TSSC3 GENE; TUMOR INITIATING CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; OSTEOSARCOMA; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; TUMOR BURDEN;

EID: 84865111700     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-012-0734-1     Document Type: Article

References (54)

1. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730-737 (Pubitemid 27298715)
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983-3988. doi: 10.1073/pnas.0530291100 (Pubitemid 36418143)
3. Pardal R, Clarke MF, Morrison SJ (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3(12):895-902. doi:10.1038/nrc1232 (Pubitemid 37500174)
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821-5828 (Pubitemid 37187480)
5. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111. doi:10.1038/35102167 (Pubitemid 33041634)
6. Davies EJ, Marsh V, Clarke AR (2011) Origin and maintenance of the intestinal cancer stem cell. Mol Carcinog 50(4):254-263. doi:10.1002/mc.20631
7. Tang N, Song WX, Luo J, Haydon RC, He TC (2008) Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 466(9):2114-2130. doi:10.1007/s11999-008-0335-z
8. Signore M, Ricci-Vitiani L, De Maria R (2011) Targeting apoptosis pathways in cancer stem cells. Cancer Lett. doi: 10.1016/j.canlet.2011.01.013
9. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN, Steindler DA (2005) Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7(11):967-976
10. Tirino V, Desiderio V, d'Aquino R, De Francesco F, Pirozzi G, Graziano A, Galderisi U, Cavaliere C, De Rosa A, Papaccio G, Giordano A (2008) Detection and characterization of CD133? cancer stem cells in human solid tumours. PLoS ONE 3(10): e3469. doi:10.1371/journal.pone.0003469
11. Veselska R, Hermanova M, Loja T, Chlapek P, Zambo I, Vesely K, Zitterbart K, Sterba J (2008) Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines. BMC Cancer 8:300. doi:10.1186/1471-2407-8-300
12. Wilson H, Huelsmeyer M, Chun R, Young KM, Friedrichs K, Argyle DJ (2008) Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J 175(1):69-75. doi:10.1016/ j.tvjl.2007.07.025 (Pubitemid 351176655)
13. Di Fiore R, Santulli A, Ferrante RD, Giuliano M, De Blasio A, Messina C, Pirozzi G, Tirino V, Tesoriere G, Vento R (2009) Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 219(2):301-313. doi:10.1002/jcp21667
14. Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, Looijenga LH (2007) OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211(1):1-9. doi:10.1002/ path.2105 (Pubitemid 46092024)
15. Tang QL, Zhao ZQ, Li JC, Liang Y, Yin JQ, Zou CY, Xie XB, Zeng YX, Shen JN, Kang T, Wang J (2011) Salinomycin inhibits osteosarcoma by targeting its tumor stem cells. Cancer Lett 311(1):113-121. doi: 10.1016/j.canlet.2011.07.016
16. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG, Di Fiore PP (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140(1):62-73. doi: 10.1016/j.cell.2009.12.007
17. Li Y, Meng G, Guo QN (2008) Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma. Exp Mol Pathol 84(3):234-239. doi: 10.1016/j.yexmp.200803013
18. Lee MP, Feinberg AP (1998) Genomic imprinting of a human apoptosis gene homologue, TSSC3. Cancer Res 58(5):1052-1056 (Pubitemid 28182478)
19. Dai H, Huang Y, Li Y, Meng G, Wang Y, Guo QN (2012) TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma. Carcinogenesis 33(1):30-40. doi:10.1093/carcin/bgr232
20. Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I, Smith A (2009) Nanog is the gateway to the pluripotent ground state. Cell 138(4):722-737. doi:10.1016/j.cell.2009.07.039
21. Zheng X, Shen G, Yang X, Liu W (2007) Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 67(8):3691-3697. doi:10.1158/0008-5472.can-06-3912 (Pubitemid 46762154)
22. Meissner A, Wernig M, Jaenisch R (2007) Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25(10):1177-1181. doi:10.1038/nbt1335 (Pubitemid 47538112)
23. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germlinecompetent induced pluripotent stem cells. Nature 448(7151): 313-317. doi:10.1038/ nature05934 (Pubitemid 47080336)
24. Pei D (2009) Regulation of pluripotency and reprogramming by transcription factors. J Biol Chem 284(6):3365-3369. doi:10.1074/ jbc.R800063200
25. Su X, Zheng X, Ni J (2009) Lanthanum citrate induces anoikis of Hela cells. Cancer Lett 285(2):200-209. doi:10.1016/j.canlet. 2009.05.018
26. ZhuXJ, ShiY, Peng J,GuoCS, ShanNN, Qin P, JiXB, HouM(2009) The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 114(26):5362-5367. doi:10.1182/blood-2009-05-217513
27. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755-768. doi:10.1038/nrc2499
28. Moon JH, Kwon S, Jun EK, Kim A, Whang KY, Kim H, Oh S, Yoon BS, You S (2011) Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells. Biochem Biophys Res Commun 412(1):175-181. doi:10.1016/ j.bbrc.2011.07.070
29. Scaffidi P, Misteli T (2011) In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol 13(9):1051-1061. doi:10.1038/ncb2308
30. Trosko JE (2009) Review paper: cancer stem cells and cancer nonstem cells: from adult stem cells or from reprogramming of differentiated somatic cells. Vet Pathol 46(2):176-193. doi:10.1354/ vp.462176
31. Li F (2009) Every single cell clones from cancer cell lines growing tumors in vivo may not invalidate the cancer stem cell concept. Mol Cells 27(4):491-492. doi:10.1007/s10059-009-0056-5
32. Kern SE, Shibata D (2007) The fuzzy math of solid tumor stem cells: a perspective. Cancer Res 67(19):8985-8988. doi:10.1158/ 0008-5472.can-07-1971 (Pubitemid 47535878)
33. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ (2008) Efficient tumour formation by single human melanoma cells. Nature 456(7222):593-598. doi:10.1038/nature 07567
34. Oliver TG, Wechsler-Reya RJ (2004) Getting at the root and stem of brain tumors. Neuron 42(6):885-888. doi:10.1016/j.neuron. 2004.06.011 (Pubitemid 38798227)
35. Hu RJ, Lee MP, Connors TD, Johnson LA, Burn TC, Su K, Landes GM, Feinberg AP (1997) A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. Genomics 46(1):9-17. doi:10.1006/geno.1997.4981 (Pubitemid 27527686)
36. Qian N, Frank D, O'Keefe D, Dao D, Zhao L, Yuan L, Wang Q, Keating M, Walsh C, Tycko B (1997) The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum Mol Genet 6(12):2021-2029 (Pubitemid 27477943)
37. Keane MM, Ettenberg SA, Lowrey GA, Russell EK, Lipkowitz S (1996) Fas expression and function in normal and malignant breast cell lines. Cancer Res 56(20):4791-4798 (Pubitemid 26338086)
38. Nagai MA, Fregnani JH, Netto MM, Brentani MM, Soares FA (2007) Down-regulation of PHLDA1 gene expression is associated with breast cancer progression. Breast Cancer Res Treat 106(1):49-56. doi:10.1007/s10549-006-9475-6 (Pubitemid 47498092)
39. Muller S, van den Boom D, Zirkel D, Koster H, Berthold F, Schwab M, Westphal M, Zumkeller W (2000) Retention of imprinting of the human apoptosis-related gene TSSC3 in human brain tumors. Hum Mol Genet 9(5):757-763 (Pubitemid 30162759)
40. Schwienbacher C, Angioni A, Scelfo R, Veronese A, Calin GA, Massazza G, Hatada I, Barbanti-Brodano G, Negrini M (2000) Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor. Cancer Res 60(6): 1521-1525 (Pubitemid 30183418)
41. Frank NY, Schatton T, Frank MH (2010) The therapeutic promise of the cancer stem cell concept. J Clin Invest 120(1):41-50. doi: 10.1172/jci41004
42. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66(19): 9339-9344. doi:10.1158/0008-5472.can-06-3126 (Pubitemid 44623625)
43. Peng S, Maihle NJ, Huang Y (2010) Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29(14):2153-2159. doi:10.1038/onc. 2009.500
44. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113(5):631-642 (Pubitemid 36694188)
45. Sell S (2004) Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51(1):1-28. doi:10.1016/j.critre vonc.2004.04.007 (Pubitemid 38781748)
46. Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S (2008) Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 68(16):6533-6540. doi:10.1158/0008-5472.can-07-6642
47. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL (2008) Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 68(15):6281-6291. doi:10.1158/0008-5472.can-08-0094
48. Jia X, Li X, Xu Y, Zhang S, Mou W, Liu Y, Lv D, Liu CH, Tan X, Xiang R, Li N (2011) SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J Mol Cell Biol 3(4):230-238. doi:10.1093/jmcb/mjr002
49. Mimeault M, Batra SK (2006) Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 24(11):2319-2345. doi:10.1634/stemcells. 2006-0066 (Pubitemid 44679695)
50. Mimeault M, Hauke R, Mehta PP, Batra SK (2007) Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 11(5):981-1011. doi:10.1111/j.1582-4934.2007.00088.x (Pubitemid 350037046)
51. Simpson CD, Anyiwe K, Schimmer AD (2008) Anoikis resistance and tumor metastasis. Cancer Lett 272(2):177-185. doi: 10.1016/j.canlet.2008.05.029
52. Mawji IA, Simpson CD, Hurren R, Gronda M, Williams MA, Filmus J, Jonkman J, Da Costa RS, Wilson BC, Thomas MP, Reed JC, Glinsky GV, Schimmer AD (2007) Critical role for Fasassociated death domain-like interleukin-1-converting enzymelike inhibitory protein in anoikis resistance and distant tumor formation. J Natl Cancer Inst 99(10):811-822. doi:10.1093/jnci/ djk182 (Pubitemid 47073526)
53. Green DR (2010) Cancer: a wolf in wolf's clothing. Nature 465(7297):433. doi:10.1038/465433a
54. Chen L, Park SM, Tumanov AV, Hau A, Sawada K, Feig C, Turner JR, Fu YX, Romero IL, Lengyel E, Peter ME (2010) CD95 promotes tumour growth. Nature 465(7297):492-496. doi: 10.1038/nature09075